The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein

Proceedings of the National Academy of Sciences of the United States of America

Volumn 95, Issue 24, 1998, Pages 14435-14440

  Puri, Anu ^a   Hug, Peter ^a   Jernigan, Kristine ^a   Barchi, Joseph ^b   Kim, Hee Yong ^d   Hamilton, Jillon ^d   Wiels, Joëlle ^e   Murray, Gary J ^c   Brady, Roscoe O ^c   Blumenthal, Robert ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^e INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ENVELOPE PROTEIN; GLOBOTRIAOSYLCERAMIDE; GLYCOSPHINGOLIPID;

ARTICLE; CELL FUSION; COLUMN CHROMATOGRAPHY; DRUG RECEPTOR BINDING; ENZYME ANALYSIS; HEAT TOLERANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE FUSION; PRIORITY JOURNAL; PROTEIN FAMILY; STRUCTURE ANALYSIS; TARGET CELL; VIRUS ENVELOPE;

ACETYLATION; ANTIGENS, CD4; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; CELL FUSION; CELL LINE; ERYTHROCYTES; GENE PRODUCTS, ENV; HELA CELLS; HIV-1; HUMANS; MASS SPECTROMETRY; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; RECEPTORS, CXCR4; TRIHEXOSYLCERAMIDES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 13144267716     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.95.24.14435     Document Type: Article

References (41)

1. Maddon, P. J., Dalgleish, A. G., McDougal, J. S., Clapham, P. R., Weiss, R. A. & Axel, R. (1986) Cell 47, 333-348.
2. Moore, J. P., Jameson, B. A., Weiss, R. A. & Sattentau, Q. J. (1993) in Viral Fusion Mechanisms, ed. Bentz, J. (CRC, Boca Raton, FL), pp. 233-289.
3. Blumenthal, R. & Dimitrov, D. S. (1997) in Handbook of Physiology, eds. Hoffman, J. F. & Jamieson, J. C. (Oxford Univ. Press, New York), pp. 563-603.
4. Berger, E. A. (1997) AIDS 11, Suppl. A, S3-S16.
5. Broder, C. C. & Dimitrov, D. S. (1996) Pathobiology 64, 171-179.
6. Moore, J. P., Trkola, A. & Dragic, T. (1997) Curr. Opin. Immunol. 9, 551-562.
7. Doms, R. W. & Peiper, S. C. (1997) Virology 235, 179-190.
8. Littman, D. R. (1998) Cell 93, 677-680.
9. Dimitrov, D. S. (1997) Cell 91, 721-730.
10. McKnight, A., Wilkinson, D., Simmons, G., Talbot, S., Picard, L., Ahuja, M., Marsh, M., Hoxie, J. A. & Clapham, P. R. (1997) J. Virol. 71, 1692-1696.
11. Bjorndal, A., Deng, H., Jansson, M., Fiore, J. R., Colognesi, C., Karlsson, A., Albert, J., Scarlatti, G., Littman, D. R. & Fenyo, E. M. (1997) J. Virol. 71, 7478-7487.
12. Dragic, T., Picard, L. & Alizon, M. (1995) J. Virol. 69, 1013-1018.
13. Puri, A., Morris, S. J., Jones, P., Ryan, M. & Blumenthal, R. (1996) Virology 219, 262-267.
14. Yahi, N., Baghdiguian, S., Moreau, H. & Fantini, J. (1992) J. Virol. 66, 4848-4854.
15. Delezay, O., Koch, N., Yahi, N., Hammache, D., Tourres, C., Tamalet, C. & Fantini, J. (1997) AIDS 11, 1311-1318.
16. Hammache, D., Pieroni, G., Yahi, N., Delezay, O., Koch, N., Lafont, H., Tamalet, C. & Fantini, J. (1998) J. Biol. Chem. 273, 7967-7971.
17. Hammache, D., Yahi, N., Pieroni, G., Ariasi, F., Tamalet, C. & Fantini, J. (1998) Biochem. Biophys. Res. Commun. 246, 117-122.
18. Picard, L., Dragic, T., Wiels, J. & Alizon, M. (1996) Perspect. Drug Discovery Des. 5, 143-153.
19. Mizrachi, Y., Lev, M., Harish, Z., Sundaram, S. K. & Rubinstein, A. (1996) J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 11, 137-141.
20. Puri, A., Hug, P., Munoz-Barroso, I. & Blumenthal, R. (1998) Biochem. Biophys. Res. Commun. 242, 219-225.
21. Wiels, J., Fellous, M. & Tursz, T. (1981) Proc. Natl. Acad. Sci. USA 78, 6485-6488.
22. Kim, H. Y., Wang, T.-C. & Ma, Y.-C. (1994) Anal. Chem. 66, 3977-3982.
23. Bax, A., Griffey, R. H. & Hawkins, L. B. (1983) J. Magn. Reson. 55, 301-315.
24. Kusiak, J. W., Quirk, J. M. & Brady, R. O. (1978) J. Biol. Chem. 253, 184-190.
25. Folch, J., Lees, M. & Stanley, G. H. S. (1957) J. Biol. Chem. 225, 497-509.
26. Watanabe, K. & Mizutsa, M. (1998) J. Lipid Res. 36, 1848-1855.
27. Kundu, S. K. (1981) Methods Enzymol. 72, 185-204.
28. Nudelman, E., Kannagi, R., Hakomori, S., Parsons, M., Lipinski M., Wiels, J., Fellous, M. & Tursz, T. (1983) Science 220, 509-511.
29. Abe, A., Inokuchi, J., Jimbo, M., Shimeno, H., Nagamatsu A., Shayman, J. A., Shukla, G. S. & Radin, N. S. (1992) J. Biochem. (Tokyo) 111, 191-196.
30. Yamakawa, T., Nishimura, S. & Kamimura, M. (1965) Jpn. J. Exp. Med. 35, 201-207.
31. Taga, S., Carlier, K., Mishal, Z., Capoulade, C., Mangeney, M., Lecluse, Y., Coulaud, D., Tetaud, C., Pritchard, L. L., Tursz T., et al. (1997) Blood 90, 2757-2767.
32. Khine, A. A., Firtel, M. & Lingwood, C. A. (1998) J. Cell. Physiol. 176, 281-292.
33. Lingwood, C. A. (1996) Trends Microbiol. 4, 147-153.
34. Ghislain, J., Lingwood, C. A. & Fish, E. N. (1994) J. Immunol. 153, 3655-3663.
35. Brady, R. O., Gal, A. E., Bradley, R. M., Martensson, E., Warshsaw, A. L. & Laster, L. (1997) N. Engl. J. Med 276, 1163-1167.
36. Zambruno, G., Giannetti, A., Bertazzoni, U. & Girolomoni, G. (1995) Immunol. Today 16, 520-524.
37. Cameron, P., Pope, M., Granelli-Piperno, A. & Steinman, R. M. (1996) J. Leukocyte Biol. 59, 158-171.
38. Ensoli, F., Wang, H., Fiorelli, V., Zeichner, S. L., De Cristofaro, M. R., Luzi, G. & Thiele, C. J. (1997) J. Neurovirol. 3, 290-298.
39. Fritsch, L., Marechal, V., Schneider, V., Barthet, C., Rozenbaum, W., Moisan-Coppey, M., Coppey, J. & Nicolas, J. C. (1998) Virology 244, 542-551.
40. Jacewicz, M. S., Acheson, D. W., Mobassaleh, M., Donohue-Rolfe, A., Balasubramanian, K. A. & Keusch, G. T. (1995) J. Clin. Invest. 96, 1328-1335.
41. Delezay, O., Hammache, D., Fantini, J. & Yahi, N. (1996) Biochemistry 35, 15663-15671.